PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12530470-0	2002	The involvement of P-glycoprotein in berberine absorption.	Berberine	37-46	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	19-33	
12530470-2	2002	The aim of this study was to use the P-glycoprotein (P-glycoprotein) inhibitors cyclosporin A, verapamil and the monoclonal antibody C219 in in vivo and in vitro models of intestinal absorption to determine the role of P-glycoprotein in berberine absorption.	Berberine	237-246	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	37-51	
12530470-2	2002	The aim of this study was to use the P-glycoprotein (P-glycoprotein) inhibitors cyclosporin A, verapamil and the monoclonal antibody C219 in in vivo and in vitro models of intestinal absorption to determine the role of P-glycoprotein in berberine absorption.	Berberine	237-246	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	53-67	
12530470-2	2002	The aim of this study was to use the P-glycoprotein (P-glycoprotein) inhibitors cyclosporin A, verapamil and the monoclonal antibody C219 in in vivo and in vitro models of intestinal absorption to determine the role of P-glycoprotein in berberine absorption.	Berberine	237-246	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	53-67	
12530470-3	2002	In the rat recirculating perfusion model, berberine absorption was improved 6-times by P-glycoprotein inhibitors.	Berberine	42-51	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	87-101	
12530470-7	2002	P-glycoprotein appears to contribute to the poor intestinal absorption of berberine which suggests P-glycoprotein inhibitors could be of therapeutic value by improving its bioavailability.	Berberine	74-83	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	0-14	
12530470-7	2002	P-glycoprotein appears to contribute to the poor intestinal absorption of berberine which suggests P-glycoprotein inhibitors could be of therapeutic value by improving its bioavailability.	Berberine	74-83	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	99-113